Calton & Associates’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Calton & Associates's ORCL Position: Q2 2026 in Review
Calton & Associates reduced its Oracle (ORCL) stake by 20% in Q2 2026, selling an estimated $380K and leaving 8,618 shares worth $1.26M. The position accounts for 0.19% of the portfolio, ranked #107.
Calton & Associates first reported a position in ORCL in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.58M in Q1 2026. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Calton & Associates held 8,618 shares of Oracle worth $1.26M as of Q2 2026.
- Calton & Associates sold 2,099 Oracle shares in Q2 2026, an estimated $380K.
- Oracle made up 0.19% of Calton & Associates's portfolio in Q2 2026, its #107 holding.
- Calton & Associates first reported a position in Oracle in Q4 2017 and has held it in 21 quarters since.
- Calton & Associates's Oracle position peaked at $1.58M in Q1 2026.
- 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.